KELLY CRITCHLEY: Open Payments
NPI 1265951990 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 60 payments from 15 companies in 2025. Trend: 2023 $1,476 · 2024 $1,327 · 2025 $1,582
Food & beverage: $1,470Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $366 |
| Teva Pharmaceuticals USA, Inc. | 4 | $195 |
| Vanda Pharmaceuticals Inc. | 8 | $183 |
| Alkermes, Inc. | 7 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $141 |
| Janssen Pharmaceuticals, Inc | 5 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Corium, LLC | 1 | $30 |
Products named: VRAYLAR, FANAPT, CAPLYTA, ARISTADA, REXULTI, INVEGA SUSTENNA, Auvelity, COBENFY.
Industry payments across CO — which companies pay providers there.
